Female Breast Cancer Status According to ER, PR and HER2 Expression: A Population Based Analysis

ISSN： 1219-4956

Source： Pathology & Oncology Research, Vol.17, Iss.3, 2011-09, pp. : 753-758

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A functional polymorphism of TGFBR2 is associated with risk of breast cancer with ER+, PR+, ER+PR+ and HER2- expression in women

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 653-658

Spandidos Publications

Access to resources Recommend Favorite

Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2924-2934

Spandidos Publications

Access to resources Recommend Favorite

Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications

By Liu Caigang Zhang Hao Shuang Chen Lu Yang Jin Feng Xu Huimian Lu Ping

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 747-752

Humana Press, Inc

Access to resources Recommend Favorite

Population-based survival-cure analysis of ER-negative breast cancer

By Huang Lan

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 257-264

Springer Publishing Company

Access to resources Recommend Favorite

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer

By Dekker T. J. A. Smit V. T. H. B. M. Hooijer G. K. J. Van de Vijver M. J. Mesker W. E. Tollenaar R. A. E. M. Nortier J. W. R. Kroep J. R.

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 931-937

Oxford University Press

Access to resources Recommend Favorite